» Articles » PMID: 35191550

A Multiparametric Fusion Deep Learning Model Based on DCE-MRI for Preoperative Prediction of Microvascular Invasion in Intrahepatic Cholangiocarcinoma

Overview
Date 2022 Feb 22
PMID 35191550
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Assessment of microvascular invasion (MVI) in intrahepatic cholangiocarcinoma (ICC) by using a noninvasive method is an unresolved issue. Deep learning (DL) methods based on multiparametric fusion of MR images have the potential of preoperative assessment of MVI.

Purpose: To investigate whether a multiparametric fusion DL model based on MR images can be used for preoperative assessment of MVI in ICC.

Study Type: Retrospective.

Population: A total of 519 patients (200 females and 319 males) with a single ICC were categorized as a training (n = 361), validation (n = 90), and an external test cohort (n = 68).

Field Strength/sequence: A 1.5 T and 3.0 T; axial T2-weighted turbo spin-echo sequence, diffusion-weighted imaging with a single-shot spin-echo planar sequence, and dynamic contrast-enhanced (DCE) imaging with T1-weighted three-dimensional quick spoiled gradient echo sequence.

Assessment: DL models of multiparametric fusion convolutional neural network (CNN) and late fusion CNN were both constructed for evaluating MVI in ICC. Gradient-weighted class activation mapping was used for visual interpretation of MVI status in ICC.

Statistical Tests: The DL model performance was assessed through the receiver operating characteristic curve (ROC) analysis, and the area under the ROC curve (AUC) with the accuracy, sensitivity, and specificity were measured. P value < 0.05 was considered as statistical significance.

Results: In the external test cohort, the proposed multiparametric fusion DL model achieved an AUC of 0.888 with an accuracy of 86.8%, sensitivity of 85.7%, and specificity of 87.0% for evaluating MVI in ICC, and the positive predictive value and negative predictive value were 63.2% and 95.9%, respectively. The late fusion DL model achieved a lower AUC of 0.866, with an accuracy of 83.8%, sensitivity of 78.6%, specificity of 85.2% for evaluating MVI in ICC.

Data Conclusion: Our DL model based on multiparametric fusion of MRI achieved a good diagnostic performance in the evaluation of MVI in ICC.

Level Of Evidence: 3 TECHNICAL EFFICACY: Stage 2.

Citing Articles

Research trends and hotspots evolution of artificial intelligence for cholangiocarcinoma over the past 10 years: a bibliometric analysis.

Wang K, Li Y, Yang S, Li F Front Oncol. 2025; 14:1454411.

PMID: 40017633 PMC: 11865243. DOI: 10.3389/fonc.2024.1454411.


Artificial Intelligence and Radiomics in Cholangiocarcinoma: A Comprehensive Review.

Zerunian M, Polidori T, Palmeri F, Nardacci S, Del Gaudio A, Masci B Diagnostics (Basel). 2025; 15(2).

PMID: 39857033 PMC: 11763775. DOI: 10.3390/diagnostics15020148.


Development of fully automated models for staging liver fibrosis using non-contrast MRI and artificial intelligence: a retrospective multicenter study.

Li C, Wang Y, Bai R, Zhao Z, Li W, Zhang Q EClinicalMedicine. 2024; 77:102881.

PMID: 39498462 PMC: 11532432. DOI: 10.1016/j.eclinm.2024.102881.


Applications of artificial intelligence in biliary tract cancers.

Gupta P, Basu S, Arora C Indian J Gastroenterol. 2024; 43(4):717-728.

PMID: 38427281 DOI: 10.1007/s12664-024-01518-0.


Application of AI on cholangiocarcinoma.

Huang J, Bai X, Qiu Y, He X Front Oncol. 2024; 14:1324222.

PMID: 38347839 PMC: 10859478. DOI: 10.3389/fonc.2024.1324222.